Programs
Benzodiazepine Education and Resources
Website and Online Resources Our website provides educational information to millions of people worldwide about the risks and safe use of prescribed benzodiazepines. In addition to original content we publish a blog featuring calls to action articles and the latest research. We also offer resources to assist patients and healthcare providers navigating benzodiazepine injury. During the year our website reached approximately 350,000 users including 349,000 new visitors who collectively engaged with our content more than 2.4 million times.This program was funded through a general operating grant of $34,500 with $9,457 allocated to this program.GeographiesNot indicatedDatesAug 1, 2024 – Jul 31, 2025Source990No causes providedNo populations provided–$9.5KSpeaking Program on Benzodiazepine Harm
Speaking and Conference Engagements In our speaking program we provide professional presentations on prescribed benzodiazepine harm and related topics at various events and conferences. During the year we presented at three events and hosted an informational booth at two additional conferences. This program was funded through a general operating grant of $34,500 with $5,830 designated for this program.GeographiesNot indicatedDatesAug 1, 2024 – Jul 31, 2025Source990No causes providedNo populations provided–$5.8KSocial Media Education and Outreach
Social Media Education and Outreach We use our social media platforms to engage directly with individuals interested in our mission. Across these channels we have built an audience of more than 28,000 followers educating the public about the potential adverse effects of prescribed benzodiazepines. During the year our YouTube channels original content received over 239,493 views and 13,215 hours of watch time. Since its launch the channel has received more than 1.5 million views and 110,933 hours of total watch time. This program was funded through a general operating grant of $34,500 with $1,284 designated for this program.GeographiesNot indicatedDatesAug 1, 2024 – Jul 31, 2025Source990No causes providedNo populations provided–$1.3K
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)